Why do I need this report?

Hair thinning can have many causes, but hormone signaling in the scalp is a major driver of female-pattern hair loss. This report helps you understand whether your CYP19A1 genetics may influence aromatase activity—an enzyme involved in converting androgens into estrogens in tissues including hair follicles. With that insight, you can make more informed choices about which treatment conversations to prioritize (and which approaches may be less relevant), saving time and reducing trial-and-error.

Why is this report unique?

This report is uniquely focused on CYP19A1 (aromatase), a key gene at the intersection of androgen and estrogen balance in hair follicles. It evaluates 3 specific variants (SNPs) associated in research with female-pattern hair loss risk and provides 1 personalized recommendation that translates your genotype into practical, clinically relevant next steps—while clearly labeling where evidence is strong and where it is still emerging.

How is the recommendations list built?

Recommendations are built by mapping your genotype across the 3 analyzed SNPs to published scientific findings on CYP19A1, aromatase biology, and hair-loss associations. Each item is prioritized based on (1) the expected impact of the variant(s) on the hormone-conversion pathway, (2) the strength and consistency of available evidence, and (3) actionability and safety considerations. When evidence is indirect—such as hypotheses about 17α-estradiol response—the report explicitly notes the limitation so you can use the information appropriately in clinician-guided decisions.

What is the CYP19A1 gene and how does it relate to female-pattern hair loss?

CYP19A1 encodes aromatase, an enzyme that converts androstenedione and testosterone into estrone and estradiol. Aromatase is present in multiple tissues, including hair follicles. Because hair follicles are sensitive to the balance between androgens and estrogens, genetic variants that alter aromatase activity may shift local hormone signaling in ways that increase susceptibility to female-pattern hair loss. This report evaluates specific CYP19A1 variants that research has associated with increased risk, helping you understand whether this pathway may be relevant to your hair-thinning pattern.

Does this DNA report tell me if topical 17α-estradiol will work for my hair loss?

The report can inform whether your genetics point to altered aromatase-related hormone balance (CYP19A1), which may be relevant to hair-loss risk. However, no studies currently show that CYP19A1 variants directly predict response to topical 17α-estradiol. 17α-estradiol is thought to act mainly by inhibiting 5-alpha-reductase (reducing DHT) and by interacting with estrogen receptors locally in the scalp. Your report explains this mechanism, summarizes what is known versus unproven, and provides a personalized, drug-focused recommendation to support an informed discussion with a healthcare professional.

Save $30

Alpha-Estradiol Response (Hair Loss)

Rated 5.00 out of 5 based on 9 customer ratings

5.0 (10 reviews)

Alpha-Estradiol Response (Hair Loss)

Rated 5.00 out of 5 based on 9 customer ratings

5.0 (10 reviews)

The report provides up to 1 personalized recommendations based on 3 genetic variants analyzed. Purchase a DNA kit to generate your genetic results. If you've already got one, you're all set to continue. View sample report.

$59

$29

Save $30

Add to cart Added

Trusted by 200,000+ users & 2,000+ doctors

Proven track record: 3+ million analyses delivered

Analyzes 3 Genetic Variants

Up to 1 DNA-Based, Science-Backed Recommendations

Alpha-Estradiol Response (Hair Loss)

$59 $29

Add to cart Added

Product features

Note: To generate your personalized report, purchase a SelfDecode DNA kit. If you already have one, you’re ready to proceed.

Understanding Your Alpha-Estradiol Response (Hair Loss) Risks: A DNA-Based Report

Noticing widening parts, thinner ponytails, or more hair in the brush—and wondering if it’s “just hormones”? Have you tried products that promise regrowth but don’t seem to match what your body needs? What if your DNA could help explain how your scalp handles the balance between androgens and estrogens that can influence female-pattern hair loss?

Key Report Highlights

The Alpha-Estradiol Response (Hair Loss) DNA Report analyzes 3 clinically relevant variants in CYP19A1 (the aromatase gene) and delivers 1 targeted, personalized recommendation. Aromatase helps convert testosterone and androstenedione into estrogens (estradiol and estrone), and variants that shift this balance have been associated with increased risk of female-pattern hair loss. Compelling context: female-pattern hair loss is common and can affect up to ~40% of women by age 50, making evidence-based, personalized guidance especially valuable.

Personalized, Actionable Recommendations

Your results are translated into a personalized action plan focused on what your genetics suggest about hormone conversion pathways that may influence hair follicle signaling. Recommendations are tailored and may include drug-focused guidance (for example, discussing topical 17α-estradiol as a treatment option to review with a clinician, or considerations around therapies that affect androgen activity on the scalp). You’ll also get clear notes on what’s supported by evidence versus what remains hypothetical—especially important because CYP19A1 variants have been linked to hair-loss risk, but have not been directly proven to predict 17α-estradiol response.

User-Friendly Format and Trust

The user-friendly format of this report emphasizes clarity, offering practical, easy-to-follow insights to integrate seamlessly into your lifestyle. Whether you’re a novice or seasoned biohacker, you’ll find the layout accessible and the information straightforward.

This report is grounded in the latest scientific research and trusted by over 150,000 users and 1,000+ doctors worldwide. It’s not only comprehensive but also complies with stringent privacy laws, being HIPAA and GDPR compliant.

Getting Started

Ready to unlock the secrets within your DNA? Purchase a DNA kit for an easy at-home collection process and gain the insights you need for a proactive, personalized approach to wellness. Don’t wait—take the first step to understanding your health today.

Product FAQs

: Hair thinning can have many causes, but hormone signaling in the scalp is a major driver of female-pattern hair loss. This report helps you understand whether your CYP19A1 genetics may influence aromatase activity—an enzyme involved in converting androgens into estrogens in tissues including hair follicles. With that insight, you can make more informed choices about which treatment conversations to prioritize (and which approaches may be less relevant), saving time and reducing trial-and-error.
: This report is uniquely focused on CYP19A1 (aromatase), a key gene at the intersection of androgen and estrogen balance in hair follicles. It evaluates 3 specific variants (SNPs) associated in research with female-pattern hair loss risk and provides 1 personalized recommendation that translates your genotype into practical, clinically relevant next steps—while clearly labeling where evidence is strong and where it is still emerging.
: Recommendations are built by mapping your genotype across the 3 analyzed SNPs to published scientific findings on CYP19A1, aromatase biology, and hair-loss associations. Each item is prioritized based on (1) the expected impact of the variant(s) on the hormone-conversion pathway, (2) the strength and consistency of available evidence, and (3) actionability and safety considerations. When evidence is indirect—such as hypotheses about 17α-estradiol response—the report explicitly notes the limitation so you can use the information appropriately in clinician-guided decisions.
: CYP19A1 encodes aromatase, an enzyme that converts androstenedione and testosterone into estrone and estradiol. Aromatase is present in multiple tissues, including hair follicles. Because hair follicles are sensitive to the balance between androgens and estrogens, genetic variants that alter aromatase activity may shift local hormone signaling in ways that increase susceptibility to female-pattern hair loss. This report evaluates specific CYP19A1 variants that research has associated with increased risk, helping you understand whether this pathway may be relevant to your hair-thinning pattern.
: The report can inform whether your genetics point to altered aromatase-related hormone balance (CYP19A1), which may be relevant to hair-loss risk. However, no studies currently show that CYP19A1 variants directly predict response to topical 17α-estradiol. 17α-estradiol is thought to act mainly by inhibiting 5-alpha-reductase (reducing DHT) and by interacting with estrogen receptors locally in the scalp. Your report explains this mechanism, summarizes what is known versus unproven, and provides a personalized, drug-focused recommendation to support an informed discussion with a healthcare professional.

WHY SELFDECODE?

Empowering Your Well-being Journey

This personalized health report is powered by SelfDecode's cutting-edge AI technology, designed to unlock a deeper understanding of your health potential. We're committed to providing you with the most accurate and actionable insights to guide your well-being journey.

Most Accurate
Polygenic Risk Scoring

We leverage cutting-edge algorithms and analyze a massive dataset of 2 million people to deliver the most precise assessment of your genetic health predispositions. Our advanced approach takes into account your ancestry - which is often overlooked by other methods - to provide you with the most accurate risk assessment. This ensures that the risk scores you receive are based on the latest scientific evidence and are truly personalized to your genetic makeup.

Cutting-Edge AI &
Machine Learning

We have invested 20 million dollars developing our AI and machine learning models. Our patent-pending technology provides you with the most personalized health insights and recommendations by taking into account your unique DNA, lifestyle, labs, symptoms, conditions and health goals. This empowers you to make informed decisions tailored to your specific needs.

Analyzes 200 Million Variants & Sophisticated Recommendation Engine

We go beyond the basics by analyzing a staggering 200 million genetic variants to provide the most comprehensive picture of your health potential. Our sophisticated recommendation engine leverages this deep analysis to provide personalized and actionable insights to optimize your well-being journey.

Built by Leading
Scientists & Engineers

A dedicated team of over 60 scientists and engineers is continuously innovating and developing our technology, ensuring it remains at the forefront of personalized health.

Reviews

Rated 5.00 out of 5 based on 9 customer ratings

5.0 (10 reviews)

Share your thoughts

If you've used this product, share your thoughts with other customers

Only customers who purchased this product can leave reviews

Brian H.

Rated 5 out of 5
alpha-estradiol response gave me a clear plan to discuss with my dermatologist, and I’m seeing new baby hairs at my temples.
Kevin O.

Rated 5 out of 5
This report explained my genetic response to topical 17-a-estradiol, I stopped guessing, and my shedding slowed within a month.
Alan C.

Rated 5 out of 5
I was skeptical but seeing my results about estradiol and hair loss was actually really eye-opening.
Rebecca A.

Rated 5 out of 5
17-a-estradiol, finally confident.
Fatima A.

Rated 5 out of 5
اشتريت تقرير Alpha-Estradiol Response (Hair Loss) لأن تساقط شعري زاد بعد الولادة، وكنت محتارة بين النصائح المتضاربة. التقرير شرح لي بشكل مبسط كيف يمكن أن تؤثر استجابتي الوراثية على فعالية 17-a-Estradiol الموضعي، وما العلامات التي أراقبها قبل وبعد البدء. أعجبني أنه وضع توصيات عملية للعناية بفروة الرأس، مثل توقيت الاستخدام والالتزام لمدة كافية قبل الحكم. أخذت التقرير لطبيب الجلدية، وساعدنا في اختيار خطة أكثر دقة بدل التجربة العشوائية. بعد أسابيع لاحظت قلة التساقط أثناء الاستحمام وتحسن كثافة مقدمة الرأس.

1 2

Alpha-Estradiol Response (Hair Loss)

Product features

Understanding Your Alpha-Estradiol Response (Hair Loss) Risks: A DNA-Based Report

Key Report Highlights

Personalized, Actionable Recommendations

User-Friendly Format and Trust

Getting Started

Product FAQs

Why do I need this report?

Why is this report unique?

How is the recommendations list built?

What is the CYP19A1 gene and how does it relate to female-pattern hair loss?

Does this DNA report tell me if topical 17α-estradiol will work for my hair loss?

WHY SELFDECODE?

Empowering Your Well-being Journey

Most AccuratePolygenic Risk Scoring

Cutting-Edge AI &Machine Learning

Analyzes 200 Million Variants & Sophisticated Recommendation Engine

Built by Leading Scientists & Engineers

Reviews

Related Products

Most Accurate
Polygenic Risk Scoring

Cutting-Edge AI &
Machine Learning

Built by Leading
Scientists & Engineers